The global C-reactive protein (CRP) testing market has experienced substantial growth in recent years, driven by the increasing prevalence of chronic and inflammatory diseases. In 2022, the industry was valued at US$ 3.1 Bn and is projected to grow at a CAGR of 2.9% from 2023 to 2031, reaching more than US$ 4.0 Bn by the end of 2031. The market expansion is primarily fueled by the rising demand for CRP testing for the diagnosis and management of cardiovascular diseases, autoimmune disorders, and infectious diseases. Additionally, advancements in CRP testing technology, such as high-sensitivity assays and point-of-care (POC) testing, are creating new growth opportunities for market players. However, challenges such as a lack of standardization in testing methods could hinder market growth.
Dive into the most impactful insights from our Report in this sample
Key Drivers and Industry Trends
Rising Prevalence of Inflammatory Diseases
One of the primary factors driving the CRP testing market is the increasing incidence of inflammatory diseases. Elevated CRP levels are an indicator of inflammation, which is commonly associated with conditions such as rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, and certain cancers. The growing burden of these diseases is leading to a higher demand for CRP testing in hospitals, diagnostic laboratories, and home care settings.
Increased Adoption of Point-of-Care Testing (POCT)
POCT for CRP is becoming increasingly popular due to its ability to provide rapid and real-time results in various healthcare settings, including primary care centers and emergency departments. This trend is particularly significant in regions with limited access to centralized laboratory facilities. The adoption of POCT has been further accelerated by the COVID-19 pandemic, which underscored the importance of quick and accurate diagnostic tools.
Advances in High-Sensitivity CRP Assays
Technological advancements in CRP testing methods, such as high-sensitivity CRP (hs-CRP) assays, have significantly improved the ability to detect low levels of inflammation. These tests are crucial for assessing cardiovascular disease risk and early-stage inflammatory conditions, thereby expanding the market’s potential applications.
Regional Outlook
North America
North America holds the largest share of the global CRP testing market, driven by the high prevalence of inflammatory diseases, strong healthcare infrastructure, and the widespread adoption of POCT. Technological advancements, coupled with the presence of key industry players, are further bolstering the market in the region.
Europe
Europe is another significant market for CRP testing, with countries like Germany, the U.K., and France leading in technological advancements and research in diagnostic testing. The rise in cardiovascular diseases and government initiatives promoting early disease detection contribute to market growth.
Asia Pacific
The Asia Pacific region is expected to witness the fastest growth due to increasing healthcare awareness, rising disposable income, and the growing burden of chronic diseases. Countries such as China, India, and Japan are investing in healthcare infrastructure and expanding access to advanced diagnostic testing.
Latin America, Middle East & Africa
While these regions hold smaller market shares, the growing focus on improving healthcare access and affordability is expected to drive CRP testing adoption in the coming years. The increasing prevalence of infectious diseases and government-led health initiatives are also key contributors to market expansion.
Competitive Landscape
The global CRP testing market is highly competitive, with major players focusing on product innovation, mergers & acquisitions, and strategic partnerships to strengthen their market position. Some of the key players include:
- Agilent Technologies, Inc.
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Creative Diagnostics
- DxGen Corp.
- CTK Biotech, Inc.
- Getein Biotech, Inc.
- Goldsite Diagnostics, Inc.
- OptiBio Co., Ltd.
- Nanjing Vazyme Biotech Co., Ltd.
Market Developments
Several key developments have shaped the CRP testing market in recent years:
- Randox Laboratories partnered with Qnostics in 2021 to develop new quality control materials for CRP testing.
- Beckman Coulter Life Sciences collaborated with Thermo Fisher Scientific in 2020 to develop a new high-sensitivity CRP assay.
- Abbott launched the Afinion 2 analyzer in May 2018, which includes CRP testing capabilities along with HbA1c and lipid panel testing.
Stay informed with the latest insights—read our full report
Market Segmentation
By Test Type:
- Standard C-reactive Protein Test
- High-sensitivity C-reactive Protein (hs-CRP) Test
By Type of Assay:
- ELISA
- Immunoturbidimetry
- Immuno-chromatography
- Immunofluorescence
- Others
By Indication:
- Heart Diseases
- Inflammatory Diseases
- Infectious Diseases
- Others
By End-user:
- Hospital-Associated Laboratories
- Independent Diagnostic Laboratories
- Others
By Region:
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Spain)
- Asia Pacific (China, India, Japan, Australia & New Zealand)
- Latin America (Brazil, Mexico)
- Middle East & Africa (South Africa, GCC Countries)
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030USA – Canada Toll Free: 866-552-3453
